Jacob Strahilevitz - Infectious Diseases

Author Information

Jacob Strahilevitz is affiliated with the Hadassah-Hebrew University School of Medicine, Jerusalem, Israel. He is also associated with the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Centre, The Hebrew University, Jerusalem, Israel. His work primarily focuses on infectious diseases, with a particular interest in clinical microbiology.

Research Contributions

Jacob Strahilevitz has contributed significantly to the field of infectious diseases, with a specific focus on topics such as infective endocarditis, antibiotic tolerance, and the immune response to SARS-CoV-2. Notable recent works include studies on the impact of socio-economic variations on infective endocarditis, the efficacy of mRNA vaccines against SARS-CoV-2, and the role of neutrophils in cerebral malaria. His research often involves prospective cohort studies, providing valuable insights into the clinical presentations and outcomes of various infections.

Aliases

Jacob Strahilevitz is also known by the aliases J Strahilevitz and J. Strahilevitz. These variations of his name may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	5901
H-index	31
Paper Count	112

Publications:

Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

DOI: 10.1007/s15010-022-01792-0

Year: 2022

Prevalence of Antibiotic Tolerance and Risk for Reinfection Among E. coli Bloodstream Isolates: A Prospective Cohort Study.

DOI: 10.1093/cid/ciac281

Year: 2022

Native aortic valve Staphylococcus warneri endocarditis after COVID‐19 infection: a case report and a review of literature

DOI: 10.1111/apm.13217

Year: 2022

Socio-Economic Variations Determine the Clinical Presentation, Aetiology and Outcome of Infective Endocarditis: a Prospective Cohort Study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) Registry.

DOI: 10.1093/ehjqcco/qcac012

Year: 2022

Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA

DOI: 10.1101/2022.02.17.480851

Year: 2022

Questioning the justification for a fourth SARS-CoV-2 vaccine

DOI: 10.1016/j.cmi.2022.03.023

Year: 2022

Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria.

DOI: 10.15252/embr.202153641

Year: 2022

Bacteremia in Children with Solid Tumors: Etiology, Antimicrobial Susceptibility, Factors Associated with Multidrug Resistance, and Mortality.

DOI: 10.1089/mdr.2021.0256

Year: 2022

Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.

DOI: 10.1016/j.jacc.2020.11.062

Year: 2021

Neutrophils impose strong selective pressure against PfEMP1 variants implicated in cerebral malaria

DOI: 10.1101/2021.05.09.443317

Year: 2021

How Effective is Handwashing in Preventing Disease Transmission?

What are the Risk Factors for Developing Dengue Hemorrhagic Fever?

How Does the Immune System Respond to Infections?

What are the limitations of RT-PCR?

What are the Risks of Untreated Infections During Pregnancy?

What is Herpes?

How are Zoonoses Transmitted?

What is Fatty Acid Biosynthesis?

Are there specific populations at higher risk for drug interactions?

How Can HPV Infection be Prevented?

Partnered Content Networks

Relevant Topics